Marion Dorsch Blueprint Medicines Corp (BPMC) insider trading activity

BPMC Quotes by TradingView

Marion Dorsch is Chief Scientific Officer of Blueprint Medicines Corp. Currently has a direct ownership of 15,250 shares of BPMC, which is worth approximately $1.33 Million. The most recent transaction as insider was on Feb 22, 2021, when has been sold 7,578 shares (Common Stock) at a price of $100.0 per share, resulting in proceeds of $757,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.3K
0% 3M change
0% 12M change
Total Value Held $1.33 Million

Marion Dorsch Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 22 2021
SELL
Open market or private sale
$757,800 $100.0 p/Share
7,578 Reduced 33.2%
15,250 Common Stock
Feb 22 2021
BUY
Exercise of conversion of derivative security
$281,220 $37.11 p/Share
7,578 Added 24.92%
22,828 Common Stock
Dec 14 2020
SELL
Open market or private sale
$547,400 $119.0 p/Share
4,600 Reduced 23.17%
15,250 Common Stock
Dec 14 2020
BUY
Exercise of conversion of derivative security
$170,706 $37.11 p/Share
4,600 Added 18.81%
19,850 Common Stock
Oct 06 2020
SELL
Open market or private sale
$455,400 $99.0 p/Share
4,600 Reduced 23.17%
15,250 Common Stock
Oct 06 2020
BUY
Exercise of conversion of derivative security
$170,706 $37.11 p/Share
4,600 Added 18.81%
19,850 Common Stock
MD

Marion Dorsch

Chief Scientific Officer
Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BPMC